- Open Access
Correlation between imaging and pathology in ductal carcinoma in situ of the breast
© de Roos et al; licensee BioMed Central Ltd. 2004
- Received: 09 December 2003
- Accepted: 12 March 2004
- Published: 12 March 2004
It is helpful in planning treatment for patients with ductal carcinoma in situ (DCIS) if the size and grade could be reliably predicted from the mammography. The aims of this study were to determine if the type of calcification can be best used to predict histopathological grade from the mammograms, to examine the association of mammographic appearance of DCIS with grade and to assess the correlation between mammographic size and pathological size.
Mammographic films and pathological slides of 115 patients treated for DCIS between 1986 and 2000 were reviewed and reclassified by a single radiologist and a single pathologist respectively. Prediction models for the European Pathologist Working Group (EPWG) and Van Nuys classifications were generated by ordinal regression. The association between mammographic appearance and grade was tested with the χ2-test. Relation of mammographic size with pathological size was established using linear regression. The relation was expressed by the correlation coefficient (r).
The EPWG classification was correctly predicted in 68%, and the Van Nuys classification in 70% if DCIS was presented as microcalcifications. High grade was associated with presence of linear calcifications (p < 0.001). Association between mammograhic- and pathological size was better for DCIS presented as microcalcifications (r = 0.89, p < 0.001) than for DCIS presented as a density (r = 0.77, p < 0.001).
Prediction of histopathological grade of DCIS presenting as microcalcifications is comparable using the Van Nuys and EPWG classification. There is no strict association of mammographic appearance with histopathological grade. There is a better linear relation between mammographic- and pathological size of DCIS presented as microcalcifications than as a density, although both relations are statistically significant.
- ductal carcinoma in situ
- pathological classification
Breast conserving therapy is now an accepted treatment modality for ductal carcinoma in situ (DCIS) of the breast. It is even suggested to omit radiation therapy after local excision under special circumstances that include small size (the lesion must be smaller than 3 cm), surgical free margins (the margins must be at least >1 cm free of tumour), and low or intermediate histopathological grade . Pathological size, surgical margins and histopathological grade are all independent predictors of recurrence that has been defined in the Van Nuys Prognostic Index . Inadequate surgical margin seems to be single most important prognostic factor for recurrence . It would be helpful in treatment planning if the size and grade could be reliably predicted from the mammogram. Mastectomy is still the golden standard in the treatment of DCIS of the breast involving large areas of DCIS (>4 cm), multiple locations and in patients where radiation therapy is contraindicated .
Several histopathological classification systems have been developed in the last decade to segregate lesions with a good prognosis from those with poor prognosis. Two classification systems that are mostly used are the European Pathologist Working Group (EPWG or EORTC) classification and the Van Nuys classification [4–6]. The DCIS is classified as high (3), intermediate (2), and low (1) grade. Essential difference between the two classifications is that the EPWG classification is based on nuclear grade and cell polarization and the Van Nuys classification uses nuclear grade and the presence of necrosis [4–6]. A previous study evaluated both classification systems in relation to relapse free survival after breast conserving therapy and found no statistical difference between the groups . There was an overall agreement between observers in 79% for the EPWG classification and in 64% for the Van Nuys classification .
With the introduction of stereotactic large core needle biopsy it has become possible to obtain a preoperative diagnosis of nonpalpable breast lesions. As most DCIS lesions are nonpalpable and some are more extensive than suspected on the mammogram, evaluation of mammographic-pathologic correlation by a multidisciplinary team is essential in the assessment of patients to determine their eligibility for breast conserving therapy, and to achieve complete surgical resection with wide free margins and a cosmetically acceptable result.
This study was carried out to determine which classification can be best used to predict histopathological grade from the mammography, to examine the association of mammographic appearance with histopathological grade and to assess the correlation between mammographic size and pathological size of DCIS. The outcome of these correlations can be used to facilitate preoperative selection of patients and planning wide local excision.
Data of all patients who were treated for DCIS of the breast at the Martini Hospital between 1986 and 2000 were selected from the database of the departments of pathology and surgery. Patients (n = 115) for whom both mammograms and pathological slides were available were included in the study. The cranio-caudal and mediolateral oblique mammographic films were subjected to review by a single radiologist (R.M.P.) with special expertise in mammography without knowledge of the histopathological subtype. The mammographic appearance was recorded as microcalcifications, a combination of microcalcifications and a density and an abnormality other than microcalcifications. Microcalcifications were classified as linear, coarse granular, fine granular or a combination of these, as defined by Holland and Hendriks [8, 9]. The amount (≤10 or >10), distribution (cluster or segment) and centricity (uni- or multicentric) of microcalcifications were recorded. A mammographic abnormality other than microcalcifications was classified as asymmetry, density, star lesion or distortion of architecture. Size of the lesion was measured as the largest diameter on the mammogram in centimeters.
Pathological slides were reviewed by a single pathologist (A.D.G.) with special expertise in breast pathology who was blinded of radiographic characteristics of the cases. Macroscopic characteristics like volume and weight of the excision specimen and the number of tissue blocks were obtained from the previous pathology reports. Microscopic findings that were being characterized consisted of histopathological grade, size and margin status. The histopathological grade was characterized according to the EPWG and Van Nuys DCIS classification [4–6]. The extent of the lesion was microscopically estimated by the number of positive slides in relation to the extent of sampling.
To examine which classification could best be used to predict histopathological grade from mammography a prediction model was created for the EPWG and van Nuys classification. Because the majority of cases were presented as microcalcifications this group was used for the prediction model.
The data was processed in SPSS® 11.0 for windows database (SPSS, Chicago, Illinois, USA). The relation between mammographic and pathological size was determined by linear regression and was expressed by the correlation coefficient (r). Association between mammographic features and histopathological grade was evaluated by the χ2-test. Significant parameters were evaluated for microcalcifications in a prediction model for both pathological classifications by ordinal regression. A p-value of ≤0.05 was considered significant.
Clinical, radiological and pathological characteristics.
Clinical, radiological and pathological characteristics
Menopausal status (n = 115)
Screening detected (n = 115)
Palpable lesion (n = 115)
Mammographic appearance (n = 115)
Abnormality other than microcalcifications
Combination of microcalcifications and a density
Mammographic appearance of microcalcifications (n = 87)
Linear and coarse granular
Coarse and fine granular
Distribution of microcalcifications (n = 87)
Centricity of microcalcifications (n = 87)
Multicentric (gap >2 cm)
Number of microcalcifications if countable (n = 87)
Mammographic appearance of abnormalities other than microcalcifications (n = 38)
Distortion of architecture
E.P.W.G. classification (n = 115)
Van Nuys classification (n = 115)
Prediction models for the EPWG and Van Nuys classification for microcalcifications.
Van Nuys classification
Association between mammographic characteristics and histo-pathologcal grade according to the E.P.W.G. classification.
Microcalcifications (n = 115)
Anormality other than microcalcifications (n = 115)
Linear microcalcifications (n = 87)
Coarse granular microcalcifications (n = 87)
Fine granular microcalcifications (n = 87)
Number of microcalcifications (n = 87)
Distribution of microcalcifications (n = 87)
The linear correlation of DCIS presented as an abnormality, other than microcalcifications was lower (r = 0,77, p < 0.001). Regression line fit equation: pathological size (PS) = 1.24+0.80 × Mammographic size (MS). In 7 cases there was a large discrepancy (>2 cm) between mammographic and pathological size. In 6 of these cases mammography underestimated the size.
This study demonstrates that there is no difference between the EPWG and Van Nuys classification in prediction of grade of DCIS from mammography when seen as microcalcifications. However, there is no association of mammographic appearance with histopathological grade. A linear relation was found between mammographic and pathological size in DCIS lesions presented as microcalcifications.
As most DCIS lesions are nonpalpable at presentation they are more difficult to excise completely. A good correlation of mammographic and pathological size and histopathological grade of DCIS might help in determining treatment. If wide local excision is decided as the treatment this may help the surgeon in better planning the excision and achieve tumour free margins while providing a cosmetically acceptable result.
The reliability of estimating preoperative size by mammography in DCIS is debatable. Size of linear microcalcifications is best predicted on mammographic films. Coarse and fine granular microcalcifications show non-significant relation [8–10]. This study showed a good correlation between the size of microcalcifications and pathological size irrespective of type of microcalcifications.
Pathological size of a mammographic abnormality other than microcalcifications has demonstrated a less reliable correlation. In 6/37 cases there was a mammographic underestimate of pathological size of more than 2 cm. In all cases the mammographic appearance was that of a density. A density on mammography is correlated with a large concentration of DCIS affected ducts on pathological examination with an epicentric extent into the periphery. It could be possible that only the large concentration of DCIS is presented as a density on mammography. The epicentric extent of DCIS into the periphery might not be visible on the mammograms. Most studies on mammographic appearance of DCIS describe microcalcifications and there are only a few studies on mammographic density and DCIS [11–17].
Reports on association of mammographic appearance with histopathological grade are conflicting [11–17]. Most studies examined only the dominant mammographic features in relation to histopathological grade. The general conclusion is that there is considerable overlap between mammographic characteristics and grade and that it is difficult to predict histopathological grade from mammography. We examined all present radiological characteristics and found several associations of mammograhic appearance with pathohistological grade. Nevertheless using ordinal regression a prediction rate of only 70% could be established.
Inter- and intra-observer variability still remains a problem in classifying microcalcifications. Pijnappel revised microcalcifications of 533 mammographic films together with a fellow radiologist. After six months a random sample of 100 out of these 533 mammograms were re-examined and classified by the same two radiologists showing a moderate intra-observer agreement . Van Nuys classification demonstrated greater inter-observer variabiltity than the EPWG classification (64% vs 79% overall agreement) .
With the introduction of stereotactic large core needle biopsy (SCNB) it has become possible to obtain a preoperative histological diagnosis in nonpalpable breast lesions. The COBRA-study, evaluating 973 patients with impalpable breast disease with SCNB and subsequent needle localised open breast biopsy, showed SCNB to be an accurate instrument for the diagnosis of nonpalpable breast disease which can reliably replace needle localized open breast biopsy . Histological diagnosis in case of microcalcifications seems to be less reliable when obtained with SCNB . We believe that careful correlation of mammographic appearance and histopathological classification by a multidisciplinary team (radiologist, pathologist and surgeon) can help improving diagnostic accuracy and assessment of patients for surgery.
Mammographic size of DCIS presented as microcalcifications can be generally used as an estimate of the pathological size when deciding on local excision. In case of a density on mammogram there is a greater chance of underestimating the size, which means that the surgeon should perform a wider excision in these cases. If SCNB is available this method should be used to determine histopathological grade of DCIS. Mammographic appearance can still be helpful in determination of a good mammographic-pathologic correlation. There is no preference for using the EPWG – or Van Nuys classification in prediction of histopathological grade of DCIS presented as microcalcifications.
- Schwartz GF, Solin LJ, Olivotto IA, Ernster VL, Pressman PI, and the consensus conference committee: The consensus conference on the treatment of in situ ductal carcinoma of the breast. Hum Pathol. 2000, 31: 131-139.View ArticlePubMedGoogle Scholar
- Silverstein MJ, Lagios MD, Craig PH, Waisman JR, Lewinsky BJ, Colburn WJ, Poller DN: A prognostic index for ductal carcinoma in situ of the breast. Cancer. 1996, 77: 2267-2274. 10.1002/(SICI)1097-0142(19960601)77:11<2267::AID-CNCR13>3.0.CO;2-V.View ArticlePubMedGoogle Scholar
- Silverstein MJ, Lagios MD, Groshen S, Waisman JR, Lewinsky BS, Martino S, Gamagami P, Colburn WJ: The influence of margin width on local control of ductal carcinoma in situ of the breast. New Engl J Med. 1999, 340: 1455-1461. 10.1056/NEJM199905133401902.View ArticlePubMedGoogle Scholar
- Shoker BS, Sloane JP: DCIS grading schemes and implications. Histopathology. 1999, 35: 393-400. 10.1046/j.1365-2559.1999.035005393.x.View ArticlePubMedGoogle Scholar
- Holland R, Peterse JL, Millis RR, Eusebi V, Faverly D, van de Vijver Holland MJ, Zafrani B: Ductal carcinoma in situ: a proposal for a new classification. Semin Diagn Pathol. 1994, 11: 167-180.PubMedGoogle Scholar
- Silverstein MJ, Poller DN, Waisman JR, Colburn WJ, Barth A, Gierson ED, Lewinsky B, Gamagami P, Slamon DJ: Prognostic classification of breast ductal carcinoma in situ. Lancet. 1995, 345: 1154-1157. 10.1016/S0140-6736(95)90982-6.View ArticlePubMedGoogle Scholar
- Wärnberg FH, Nordgren H, Bergh J, Holmberg L: Ductal carcinoma in situ of the breast from a population-defined cohort: an evaluation of new histopatological classification systems. Eur J Cancer. 1999, 35: 714-720. 10.1016/S0959-8049(99)00010-6.View ArticlePubMedGoogle Scholar
- Holland R, Hendriks JHCL, Verbeek ALM, Mravunac M, Schuurmans Stekhoven JH: Extent, distribution, and mammographic/histological correlations of breast ductal carcinoma in situ. Lancet. 1990, 335: 519-522. 10.1016/0140-6736(90)90747-S.View ArticlePubMedGoogle Scholar
- Holland R, Hendriks JHCL: Microcalcifications associated with ductal carcinoma in situ: mammographic-pathologic correlation. Semin Diagn Pathol. 1994, 11: 181-192.PubMedGoogle Scholar
- Coombs JH, Hubbard E: Ductal carcinoma in situ of the breast: correlation of pathologic and mammographic features with the extent of disease. Am Surg. 1997, 63: 1079-1086.PubMedGoogle Scholar
- Stomper P, Conolly J, Meyer J, Harris J: Clinically occult ductal carcinoma in situ detected with mammography: analysis of 100 cases with radiologic-pathologic correlation. Radiology. 1989, 172: 235-241.View ArticlePubMedGoogle Scholar
- Stomper PC, Connolly JL: Ductal carcinoma in situ of the breast: correlation between mammographic calcification and tumor subtype. Am J Roentgen. 1992, 159: 483-485.View ArticleGoogle Scholar
- Evans A, Pinder S, Ellis I, Sibbering M, Elston CW, Poller DN, Wilson R: Screening-detected and symptomatic ductal carcinoma in situ: mammographic features with pathologic correlation. Radiology. 1994, 191: 237-240.View ArticlePubMedGoogle Scholar
- Evans A, Pinder S, Wilson R, Sibbering M, Poller D, Elston C, Ellis I: Ductal carcinoma in situ of the breast: correlation between mammographic and pathologic findings. Am J Roentgen. 1994, 162: 1307-1311.View ArticleGoogle Scholar
- Dinkel H, Gassel A, Tschammler A: Is the appearance of microcalcifications on mammography useful in predicting histological grade of malignancy in ductal cancer in situ. Br J Radiol. 2000, 73: 938-944.View ArticlePubMedGoogle Scholar
- Hermann G, Keller R, Drossman S, Caravella BA, Tartter P, Panetta RA, Bleiweiss IJ: Mammographic pattern of microcalcifications in the preoperative diagnosis of comedo ductal carcinoma in situ: histopathologic correlation. Can Assoc Radiol J. 1999, 50: 235-240.PubMedGoogle Scholar
- Slanetz PJ, Giardino AA, Oyama T, Koerner FC, Halpern EF, Moore RH, Kopans DB: Mammographic appearance of ductal carcinoma in situ does not reliably predict histologic subtype. Breast J. 2001, 7: 417-421. 10.1046/j.1524-4741.2001.07607.x.View ArticlePubMedGoogle Scholar
- Pijnappel RM: The diagnosis of nonpalpable breast lesions. PhD Thesis. 2002, Utrecht, University of UtrechtGoogle Scholar
- Verkooijen HM, Peeters PHM, Borel Rinkes IHM, Mali WPThM, Van Vroonhoven ThJMV: Diagnostic accuracy of stereotactic large-core needle biopsy for nonpalpable breast disease: results of a multcenter prospective study with 95% surgical confirmation. Int J Cancer. 2002, 99: 853-859. 10.1002/ijc.10419.View ArticlePubMedGoogle Scholar
This article is published under license to BioMed Central Ltd. This is an Open Access article: verbatim copying and redistribution of this article are permitted in all media for any purpose, provided this notice is preserved along with the article's original URL.